These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

130 related articles for article (PubMed ID: 28363445)

  • 1. Erratum to "Synthesis, biological evaluation, and physicochemical property assessment of 4-substituted 2-phenylaminoquinazolines as Mer tyrosine kinase inhibitors" [Bioorg. Med. Chem. 24 (2016) 3083-3092].
    Wang SB; Cui MT; Wang XF; Ohkoshi E; Goto M; Yang DX; Li L; Yuan S; Morris-Natschke SL; Lee KH; Xie L
    Bioorg Med Chem; 2017 May; 25(9):2676-2678. PubMed ID: 28363445
    [No Abstract]   [Full Text] [Related]  

  • 2. Erratum to "Discovery and optimization of a series of imidazo[4,5-b]pyrazine derivatives as highly potent and exquisitely selective inhibitors of the mesenchymal-epithelial transition factor (c-Met) protein kinase" [Bioorg. Med. Chem. 24 (2016) 4281-4290].
    Zhao F; Zhang J; Zhang L; Hao Y; Shi C; Xia G; Yu J; Liu Y
    Bioorg Med Chem; 2017 May; 25(10):2811-2812. PubMed ID: 28389111
    [No Abstract]   [Full Text] [Related]  

  • 3. Erratum to "Optimization of physicochemical properties of pyridone-based EP3 receptor antagonists" [Bioorg. Med. Chem. Lett. 47 (2021) 128172].
    Zhang X; Zhu B; Guo L; Bakaj I; Rankin M; Ho G; Kauffman J; Lee SP; Norquay L; Macielag M
    Bioorg Med Chem Lett; 2021 Sep; 47():128232. PubMed ID: 34218118
    [No Abstract]   [Full Text] [Related]  

  • 4. Corrigendum to "Discovery of substituted 6-pheny-3H-pyridazin-3-one derivatives as novel c-Met kinase inhibitors" [Bioorg. Med. Chem. Lett. 24 (2014) 5093-5097].
    Kang ST; Kim EY; Achary R; Jung H; Park CH; Yun CS; Hwang JY; Choi SU; Chae C; Lee CO; Kim HR; Ha JD; Ryu D; Cho SY
    Bioorg Med Chem Lett; 2017 Jul; 27(14):3205. PubMed ID: 28551102
    [No Abstract]   [Full Text] [Related]  

  • 5. Retraction notice to "Design, synthesis, structure-activity relationship and kinase inhibitory activity of substituted 3-methyl-1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-ones" [Bioorg. Med. Chem. Lett. 26 (2016) 3093-3097].
    Lamie PF
    Bioorg Med Chem Lett; 2017 Sep; 27(17):4220. PubMed ID: 28826507
    [No Abstract]   [Full Text] [Related]  

  • 6. Erratum to "Synthesis, F-18 radiolabeling, and microPET evaluation of 3-(2,4-dichlorophenyl)-N-alkyl-N-fluoroalkyl-2,5-dimethylpyrazolo[1,5-a]pyrimidin-7-amines as ligands of the corticotropin-releasing factor type-1 (CRF1) receptor" [Bioorg. Med. Chem. 23 (2015) 4286-4302].
    Stehouwer JS; Birnbaum MS; Voll RJ; Owens MJ; Plott SJ; Bourke CH; Wassef MA; Kilts CD; Goodman MM
    Bioorg Med Chem; 2020 Oct; 28(19):115660. PubMed ID: 32747078
    [No Abstract]   [Full Text] [Related]  

  • 7. Corrigendum to "Synthesis and carbonic anhydrase inhibitory properties of novel chalcone substituted benzenesulfonamides" [Bioorg. Med. Chem. Lett. 26 (2016) 5867-5870].
    Arslan T; Türkoğlu EA; Şentürk M; Supuran CT
    Bioorg Med Chem Lett; 2017 Aug; 27(16):3944. PubMed ID: 28705642
    [No Abstract]   [Full Text] [Related]  

  • 8. Corrigendum to "Design, synthesis and biological evaluation of amino acids-oleanolic acid conjugates as influenza virus inhibitors" [Bioorg. Med. Chem. 27 (2019) 115147].
    Meng L; Su Y; Yang F; Xiao S; Yin Z; Liu J; Zhong J; Zhou D; Yu F
    Bioorg Med Chem; 2020 Feb; 28(4):115293. PubMed ID: 31892438
    [No Abstract]   [Full Text] [Related]  

  • 9. Corrigendum to "Design, synthesis and biological evaluation of macrocyclic derivatives as TRK inhibitors" [Bioorg. Med. Chem. Lett. 53 (2021) 128409].
    Li P; Cai S; Zhao T; Xu L; Guan D; Li J; Zhou J; Zhang H
    Bioorg Med Chem Lett; 2022 Jan; 56():128502. PubMed ID: 34906405
    [No Abstract]   [Full Text] [Related]  

  • 10. Corrigendum to "Synthesis and biological evaluation of novel benzamide derivatives as potent smoothened antagonists" [Bioorg. Med. Chem. Lett. 24/5 (2014) 1426-1431].
    Wu TM; Wang DC; Xiang P; Zhang JN; Sang YX; Lin HJ; Chen J; Xie G; Song H; Zhao YL; Xie YM
    Bioorg Med Chem Lett; 2016 Sep; 26(18):4558. PubMed ID: 27542309
    [No Abstract]   [Full Text] [Related]  

  • 11. Corrigendum to "Identification of substituted benzothiazole sulfones as potent and selective inhibitors of endothelial lipase" [Bioorg. Med. Chem. Lett. 29 (2019) 1918-1921].
    Kim SH; Johnson JA; Jiang J; Parkhurst B; Phillips M; Pi Z; Qiao JX; Tora G; Ye Chen A; Liu E; Yin X; Yang R; Zhao L; Taylor DS; Basso M; Behnia K; Onorato J; Chen XQ; Abell LM; Lu H; Locke G; Caporuscio C; Adam LP; Gordon D; Wexler RR; Finlay HJ
    Bioorg Med Chem Lett; 2019 Sep; 29(17):2525. PubMed ID: 31353296
    [No Abstract]   [Full Text] [Related]  

  • 12. Corrigendum to "Design, synthesis and biological evaluation of imidazopyridazine derivatives containing isoquinoline group as potent MNK1/2 inhibitors" [Bioorg. Med. Chem. 40 (2021) 116186].
    Bu H; Yuan X; Wu H; Zhou J; Zhang H
    Bioorg Med Chem; 2022 Jan; 54():116578. PubMed ID: 34920926
    [No Abstract]   [Full Text] [Related]  

  • 13. Erratum to "A triple exon-skipping luciferase reporter assay identifies a new CLK inhibitor pharmacophore" [Bioorg. Med. Chem. Lett. 27 (2017) 406-412].
    Shi Y; Park J; Lagisetti C; Zhou W; Sambucetti LC; Webb TR
    Bioorg Med Chem Lett; 2017 Mar; 27(6):1488-1489. PubMed ID: 28214076
    [No Abstract]   [Full Text] [Related]  

  • 14. Erratum to "Discovery of N-arylpyrroles as agonists of GPR120 for the treatment of type II diabetes" Bioorg. Med. Chem. Lett. 28 (2018) [841-846].
    Winters MP; Sui Z; Wall M; Wang Y; Gunnet J; Leonard J; Hua H; Yan W; Suckow A; Bell A; Clapper W; Jenkinson C; Haug P; Koudriakova T; Huebert N; Murray WV
    Bioorg Med Chem Lett; 2018 May; 28(9):1676-1678. PubMed ID: 29605534
    [No Abstract]   [Full Text] [Related]  

  • 15. Erratum to "Fluoroquinolones structural and medicinal developments (2013-2018): Where are we now?" [Bioorg. Med. Chem. 27 (2019) 3005-3060].
    Suaifan GARY; Mohammed AAM
    Bioorg Med Chem; 2019 Nov; 27(21):115072. PubMed ID: 31537435
    [No Abstract]   [Full Text] [Related]  

  • 16. Corrigendum to 'Design and synthesis of Coenzyme A analogues as Aurora kinase A inhibitors: An exploration of the roles of the pyrophosphate and pantetheine moieties'. [Bioorg. Med. Chem. 28 (2020) 115740].
    Bellany F; Tsuchiya Y; Tran TM; Edith Chan AW; Allan H; Gout I; Tabor AB
    Bioorg Med Chem; 2021 Jun; 40():116106. PubMed ID: 33985868
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Corrigendum to "Identification of 2-substituted pyrrolo[1,2-b]pyridazine derivatives as new PARP-1 inhibitors" [Bioorg. Med. Chem. Lett. 31 (2021) 127710].
    Xiang HY; Chen JY; Huan XJ; Chen Y; Gao ZB; Ding J; Miao ZH; Yang CH
    Bioorg Med Chem Lett; 2022 Jan; 56():128501. PubMed ID: 34911648
    [No Abstract]   [Full Text] [Related]  

  • 18. Corrigendum to "Design, synthesis, biological evaluation, and molecular docking of chalcone derivatives as anti-inflammatory agents" [Bioorg. Med. Chem. Lett. 27 (3) (2017) 602-606].
    Li J; Li D; Xu Y; Guo Z; Liu X; Yang H; Wu L; Wang L
    Bioorg Med Chem Lett; 2018 Dec; 28(23-24):3822. PubMed ID: 30385163
    [No Abstract]   [Full Text] [Related]  

  • 19. Corrigendum to "Design and synthesis of bicyclic acetals as Beta Secretase (BACE1) inhibitors" [Bioorg. Med. Chem. 25 (2017) 5077-5083].
    Innocenti R; Lenci E; Menchi G; Pupi A; Trabocchi A
    Bioorg Med Chem; 2017 Dec; 25(24):6724-6725. PubMed ID: 29111366
    [No Abstract]   [Full Text] [Related]  

  • 20. Erratum to "Defined concatenated α6α1β3γ2 GABAA receptor constructs reveal dual action of pyrazoloquinolinone allosteric modulators" [Bioorg. Med. Chem. 27 (2019) 3167-3178].
    Simeone X; Iorio MT; Siebert DCB; Rehman S; Schnürch M; Mihovilovic MD; Ernst M
    Bioorg Med Chem; 2020 Apr; 28(8):115417. PubMed ID: 32184041
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.